FBN1 and dilated cardiomyopathy: Whereas fewer studies have been conducted on the relationship between Asprosin and HF, only one study confirmed that circulating Asprosin levels were significantly higher in patients with dilated cardiomyopathy than in healthy controls and that patients with lower plasma Asprosin levels had a higher risk of adverse cardiovascular events than patients with higher plasma Asprosin levels [12].